Ulland Investment Advisors’s ResMed RMD Stock Holding History

Ulland Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5K	Hold	25	–	–	﹤0.01%	202
2026 Q1	$6K	Hold	25	–	–	0.01%	186
2025 Q4	$6K	Hold	25	–	–	﹤0.01%	181
2025 Q3	$7K	Hold	25	–	–	0.01%	185
2025 Q2	$6K	Hold	25	–	–	﹤0.01%	183
2025 Q1	$6K	Hold	25	–	–	0.01%	189
2024 Q4	$6K	Hold	25	–	–	﹤0.01%	185
2024 Q3	$6K	Hold	25	–	–	﹤0.01%	178
2024 Q2	$5K	Hold	25	–	–	﹤0.01%	192
2024 Q1	$5K	Hold	25	–	–	﹤0.01%	196
2023 Q4	$4K	Hold	25	–	–	﹤0.01%	177
2023 Q3	$4K	Hold	25	–	–	﹤0.01%	191
2023 Q2	$5K	Hold	25	–	–	0.01%	187
2023 Q1	$5K	Hold	25	–	–	0.01%	178
2022 Q4	$5K	Hold	25	–	–	0.01%	185
2022 Q3	$5K	Hold	25	–	–	0.01%	190
2022 Q2	$5K	Hold	25	–	–	0.01%	214
2022 Q1	$6K	Hold	25	–	–	﹤0.01%	224
2021 Q4	$7K	Buy	+25	New	+$6.49K	﹤0.01%	184

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

CISOA

Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Ulland Investment Advisors's RMD Position: Q2 2026 in Review

Ulland Investment Advisors held its ResMed (RMD) position steady in Q2 2026 at 25 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #202.

Ulland Investment Advisors first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $7K in Q3 2025. 156 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Ulland Investment Advisors held 25 shares of ResMed worth $5K as of Q2 2026.
Ulland Investment Advisors left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Ulland Investment Advisors's portfolio in Q2 2026, its #202 holding.
Ulland Investment Advisors first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
Ulland Investment Advisors's ResMed position peaked at $7K in Q3 2025.
156 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.